cholestyramine resin has been researched along with dronabinol in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (dronabinol) | Trials (dronabinol) | Recent Studies (post-2010) (dronabinol) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 8,307 | 785 | 3,094 |
| Protein | Taxonomy | cholestyramine resin (IC50) | dronabinol (IC50) |
|---|---|---|---|
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.218 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 0.0028 | |
| Cannabinoid receptor 2 | Homo sapiens (human) | 0.0095 | |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.218 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blumenstein, I; Schirrmacher, S; Stein, J | 1 |
1 other study(ies) available for cholestyramine resin and dronabinol
| Article | Year |
|---|---|
[Pathogenesis and treatment of pruritus in patients with cholestasis].
Topics: Brain; Cholestasis; Cholestyramine Resin; Dronabinol; Enzyme Induction; Humans; Liver; Narcotic Antagonists; Ondansetron; Opioid Peptides; Phenobarbital; Pruritus; Rifampin; Skin; Synaptic Transmission; Treatment Outcome | 2003 |